Skip to main content
SpringerLink
Log in

Transfemoral aortic valve implantation: bleeding events, related costs and outcomes

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Although less invasive then SAVR, TAVI is associated with a significant rate of access site and non-access site bleeding. These complications are major determinants of therapy outcome, however, the economic consequences are not well defined. The purpose of this study was to determine the relationship between bleeding, in-hospital resource utilization and costs among patients undergoing transfemoral aortic valve implantation (TF-AVI) at a representative university hospital in Germany. Between February 2010 and December 2011, we prospectively enrolled 60 consecutive patients undergoing TAVI using a 18F transfemoral approach at our institution. The relationship between overt bleeding (OVB), defined according to the definitions provided by the Valve Academic Research Consortium, in-hospital resource utilization and in-hospital costs was investigated. The mean age was 82 (±6) years, 53 % were female and the mean EuroScore was 17.2 % (±8, 7). Thirty-eight percent (23/60) of the patients had an OVB following TF-AVI procedure. In-hospital mortality was 8.7 % in the OVB patients (2/23) and 2.7 % among patients without any OVB (1/37; NOVB), which was not statistically significant (p = 0.3). The total length of stay (LOS) of patients with and without bleeding complication were 15.0 ± 6.4 and 10.4 ± 5.1 days, respectively (p < 0.01). Time spent on ICU in the OVB group was twice as long as compared to the NOVB group (120.5 ± 98.5 min vs. 63.6 ± 26.5 min, p < 0.01). Consequently, in-hospital costs were statistically significant higher in OVB patients (40.051 ± 9.293€ vs. 33.625 ± 4.368€, p < 0.01). Bleeding is associated with increased resource use and in-hospital costs among TF-AVI patients. Our data indicates that strategies reducing bleeding risk may have the potential to generate important in-hospital costs reductions in TF-AVI patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses JW, Williams MR, Siegel RJ, Akin JJ, Anderson WN, Pocock S, Smith CR, Leon MB (2012) Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 366:1696–1704

    Article  PubMed  CAS  Google Scholar 

  2. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198

    Article  PubMed  CAS  Google Scholar 

  3. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB (2012) Two year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 366:1686–1695

    Article  PubMed  CAS  Google Scholar 

  4. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607

    Article  PubMed  CAS  Google Scholar 

  5. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106:3006–3008

    Article  PubMed  Google Scholar 

  6. Nuis RJ, Piazza N, Van Mieghem NM, Otten AM, Tzikas A, Schultz CJ, van der Boon R, van Geuns RJ, van Domburg RT, Koudstaal PJ, Kappetein AP, Serruys PW, de Jaegere PP (2011) In-hospital complications after transcatheter aortic valve implantation revisited according to the valve academic research consortium definitions. Catheter Cardiovasc Interv 78:457–467

    PubMed  Google Scholar 

  7. Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Colombo A, Lange R, Schwarz RR, Wendler O (2011) One year outcomes of cohort 1 in the Edwards sapien aortic bioprosthesis european outcome (source) registry: the european registry of transcatheter aortic valve implantation using the Edwards sapien valve. Circulation 124:425–433

    Article  PubMed  Google Scholar 

  8. Van Mieghem NM, Nuis RJ, Piazza N, Apostolos T, Ligthart J, Schultz C, de Jaegere PP, Serruys PW (2010) Vascular complications with transcatheter aortic valve implantation using the 18 fr medtronic corevalve system: the rotterdam experience. EuroIntervention 5:673–679

    Article  PubMed  Google Scholar 

  9. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW (2008) Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following ce mark approval. EuroIntervention 4:242–249

    Article  PubMed  Google Scholar 

  10. Lefevre T, Kappetein AP, Wolner E, Nataf P, Thomas M, Schachinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Serruys P, Wimmer-Greinecker G (2011) One year follow-up of the multi-centre european partner transcatheter heart valve study. Eur Heart J 32:148–157

    Article  PubMed  Google Scholar 

  11. Wenaweser P, Pilgrim T, Roth N, Kadner A, Stortecky S, Kalesan B, Meuli F, Bullesfeld L, Khattab AA, Huber C, Eberle B, Erdos G, Meier B, Juni P, Carrel T, Windecker S (2011) Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J 161:1114–1124

    Article  PubMed  Google Scholar 

  12. Genereux P, Head SJ, Van Mieghem NM, Kodali S, Kirtane AJ, Xu K, Smith C, Serruys PW, Kappetein AP, Leon MB (2012) Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol 59:2317–2326

    Article  PubMed  Google Scholar 

  13. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP (2011) Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123:299–308

    Article  PubMed  Google Scholar 

  14. Rao SV, Kaul PR, Liao L, Armstrong PW, Ohman EM, Granger CB, Califf RM, Harrington RA, Eisenstein EL, Mark DB (2008) Association between bleeding, blood transfusion, and costs among patients with non-st-segment elevation acute coronary syndromes. Am Heart J 155:369–374

    Article  PubMed  Google Scholar 

  15. Weintraub WS, Mahoney EM, Lamy A, Culler S, Yuan Y, Caro J, Gabriel S, Yusuf S (2005) Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation. J Am Coll Cardiol 45:838–845

    Article  PubMed  CAS  Google Scholar 

  16. Kessler DP, Kroch E, Hlatky MA (2011) The effect of bivalirudin on costs and outcomes of treatment of st-segment elevation myocardial infarction. Am Heart J 162:494–500 e492

    Article  PubMed  CAS  Google Scholar 

  17. Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, White HD, Pocock SJ, Ware JH, Feit F, Colombo A, Aylward PE, Cequier AR, Darius H, Desmet W, Ebrahimi R, Hamon M, Rasmussen LH, Rupprecht HJ, Hoekstra J, Mehran R, Ohman EM (2006) Bivalirudin for patients with acute coronary syndromes. N Engl J Med 355:2203–2216

    Article  PubMed  CAS  Google Scholar 

  18. Cohen DJ, Lincoff AM, Lavelle TA, Chen HL, Bakhai A, Berezin RH, Jackman D, Sarembock IJ, Topol EJ (2004) Economic evaluation of bivalirudin with provisional glycoprotein iib/iiia inhibition versus heparin with routine glycoprotein iib/iiia inhibition for percutaneous coronary intervention: results from the replace-2 trial. J Am Coll Cardiol 44:1792–1800

    PubMed  CAS  Google Scholar 

  19. Pinto DS, Stone GW, Shi C, Dunn ES, Reynolds MR, York M, Walczak J, Berezin RH, Mehran R, McLaurin BT, Cox DA, Ohman EM, Lincoff AM, Cohen DJ (2008) Economic evaluation of bivalirudin with or without glycoprotein iib/iiia inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes. J Am Coll Cardiol 52:1758–1768

    Article  PubMed  CAS  Google Scholar 

  20. Allareddy V, Ward MM, Ely JW, Levett J (2007) Impact of complications on outcomes following aortic and mitral valve replacements in the United States. J Cardiovasc Surg (Torino) 48:349–357

    CAS  Google Scholar 

  21. Cohn LH, Adams DH, Couper GS, Bichell DP, Rosborough DM, Sears SP, Aranki SF (1997) Minimally invasive cardiac valve surgery improves patient satisfaction while reducing costs of cardiac valve replacement and repair. Ann Surg 226:421–426 discussion 427–428

    Article  PubMed  CAS  Google Scholar 

  22. Caro JJ, Migliaccio-Walle K, O’Brien JA (1996) The cost of treating heart valve related complications. J Heart Valve Dis 5:122–127

    PubMed  CAS  Google Scholar 

  23. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding corevalve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50:69–76

    Article  PubMed  Google Scholar 

  24. Otten AM, van Domburg RT, van Gameren M, Kappetein AP, Takkenberg JJ, Bogers AJ, Serruys PW, de Jaegere PP (2008) Population characteristics, treatment assignment and survival of patients with aortic stenosis referred for percutaneous valve replacement. EuroIntervention 4:250–255

    Article  PubMed  Google Scholar 

  25. Delgado V, Ng AC, Shanks M, van der Kley F, Schuijf JD, van de Veire NR, Kroft L, de Roos A, Schalij MJ, Bax JJ (2010) Transcatheter aortic valve implantation: role of multimodality cardiac imaging. Expert Rev Cardiovasc Ther 8:113–123

    Article  PubMed  Google Scholar 

  26. Rodes-Cabau J (2012) Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol 9:15–29

    Article  Google Scholar 

  27. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW (2011) Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the valve academic research consortium. Eur Heart J 32:205–217

    Article  PubMed  Google Scholar 

  28. Kramer N (2009) Strategisches kostenmanagement im krankenhaus: neue konzeptionen erforderlich. Das Krankenhaus 11:1036–1044

    Google Scholar 

  29. Vogl M (2012) Assessing drg cost accounting with respect to resource allocation and tariff calculation: the case of Germany. Health Econ Rev 2:15

    Article  PubMed  Google Scholar 

  30. Institut für das Entgeltsystem im Krankenhaus: Handbuch ur Kalkulation von Fallkosten Version 3.0 (2007). Deutsche Krankenhaus Verlagsgesellschaft GmbH, Düsseldorf

  31. Ducrocq G, Francis F, Serfaty JM, Himbert D, Maury JM, Pasi N, Marouene S, Provenchere S, Iung B, Castier Y, Leseche G, Vahanian A (2010) Vascular complications of transfemoral aortic valve implantation with the Edwards sapien prosthesis: incidence and impact on outcome. EuroIntervention 5:666–672

    Article  PubMed  Google Scholar 

  32. Kahlert P, Al-Rashid F, Weber M, Wendt D, Heine T, Kottenberg E, Thielmann M, Kuhl H, Peters J, Jakob HG, Sack S, Erbel R, Eggebrecht H (2009) Vascular access site complications after percutaneous transfemoral aortic valve implantation. Herz 34:398–408

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Heart Center Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany

    Jochen Reinöhl, Anja Gutmann, Marc Kollum, Constantin von zur Mühlen, Melanie Avlar, Martin Moser, Christoph Bode & Manfred Zehender

  2. Department of Cardiovascular Surgery, Robert-Bosch-Krankenhaus, Stuttgart, Germany

    Hardy Baumbach

  3. Department of Cardiology, HBH-Kliniken, Singen, Germany

    Marc Kollum

Authors
  1. Jochen Reinöhl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anja Gutmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marc Kollum
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Constantin von zur Mühlen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hardy Baumbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Melanie Avlar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Martin Moser
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Christoph Bode
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Manfred Zehender
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jochen Reinöhl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reinöhl, J., Gutmann, A., Kollum, M. et al. Transfemoral aortic valve implantation: bleeding events, related costs and outcomes. J Thromb Thrombolysis 35, 469–475 (2013). https://doi.org/10.1007/s11239-012-0829-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-012-0829-0

Keywords

Search

Navigation